Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Clinical trial NCT04848753 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04848753
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2027-05-12
- Enrollment
- 663
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.